このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Day One Biopharmaceuticals マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Jeremy Bender
最高経営責任者
US$6.9m
報酬総額
| CEO給与比率 | 9.4% |
| CEO在任期間 | 4yrs |
| CEOの所有権 | 1.7% |
| 経営陣の平均在職期間 | 3yrs |
| 取締役会の平均在任期間 | 3.5yrs |
経営陣の近況
Recent updates
We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Afford To Drive Business Growth
Jul 12
Day One Biopharmaceuticals: Still Uncertainty After FDA Approval
Jul 07Day One Pharmaceuticals: Ojemda Approval A Big Win, Current Valuation Fair
Apr 24We're Hopeful That Day One Biopharmaceuticals (NASDAQ:DAWN) Will Use Its Cash Wisely
Mar 18Navigating Day One Biopharmaceuticals' Financial Health And Clinical Prospects
Feb 01We're Hopeful That Day One Biopharmaceuticals (NASDAQ:DAWN) Will Use Its Cash Wisely
Dec 04We're Not Very Worried About Day One Biopharmaceuticals' (NASDAQ:DAWN) Cash Burn Rate
Jun 19We're Hopeful That Day One Biopharmaceuticals (NASDAQ:DAWN) Will Use Its Cash Wisely
Mar 08Here's Why We're Not Too Worried About Day One Biopharmaceuticals' (NASDAQ:DAWN) Cash Burn Situation
Nov 22Day One Biopharmaceuticals: Recent Strong Data, And Major Catalysts Ahead
Sep 04Day One Biopharmaceuticals GAAP EPS of -$0.60
Aug 04Day One Biopharmaceuticals, Inc.'s (NASDAQ:DAWN) Intrinsic Value Is Potentially 52% Above Its Share Price
Jun 18Day One Biopharmaceuticals: Early Pediatric Brain Cancer Data Makes Tentative Buy Case
Jun 15We're Not Very Worried About Day One Biopharmaceuticals' (NASDAQ:DAWN) Cash Burn Rate
Apr 29An Intrinsic Calculation For Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Suggests It's 42% Undervalued
Jan 14Day One Biopharmaceuticals (NASDAQ:DAWN) Is In A Good Position To Deliver On Growth Plans
Dec 10Day One Biopharmaceuticals (NASDAQ:DAWN) Is In A Good Position To Deliver On Growth Plans
Aug 27Day One Biopharma draws bullish calls as quiet period ends
Jun 21CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$167m |
| Mar 31 2024 | n/a | n/a | -US$209m |
| Dec 31 2023 | US$7m | US$647k | -US$189m |
| Sep 30 2023 | n/a | n/a | -US$175m |
| Jun 30 2023 | n/a | n/a | -US$166m |
| Mar 31 2023 | n/a | n/a | -US$157m |
| Dec 31 2022 | US$5m | US$610k | -US$142m |
| Sep 30 2022 | n/a | n/a | -US$124m |
| Jun 30 2022 | n/a | n/a | -US$105m |
| Mar 31 2022 | n/a | n/a | -US$183m |
| Dec 31 2021 | US$20m | US$523k | -US$171m |
| Sep 30 2021 | n/a | n/a | -US$183m |
| Jun 30 2021 | n/a | n/a | -US$167m |
| Mar 31 2021 | n/a | n/a | -US$54m |
| Dec 31 2020 | US$3m | US$142k | -US$41m |
報酬と市場: Jeremyの 総報酬 ($USD 6.91M ) は、 US市場 ($USD 5.65M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Jeremyの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Jeremy Bender (53 yo)
4yrs
在職期間
US$6,913,959
報酬
Dr. Jeremy Bender, Ph D., M.B.A. serves as Chief Executive Officer, President and Director of Day One Biopharmaceuticals, Inc. since September 2020. He serves as President, Chief Executive Officer and Dire...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Director | 4yrs | US$6.91m | 1.71% $ 24.2m | |
| Co-Founder and Head of R&D | 6.7yrs | US$2.49m | 2.1% $ 29.7m | |
| COO, CFO & Secretary | 3.6yrs | US$3.55m | 0.23% $ 3.3m | |
| General Counsel and Chief Compliance Officer | 1.9yrs | US$2.77m | 0.027% $ 381.3k | |
| Chief Technology Officer | no data | データなし | データなし | |
| Chief People Officer | 3yrs | データなし | データなし | |
| Chief Development Officer | no data | データなし | データなし | |
| Chief Commercial Officer | 1.7yrs | データなし | データなし | |
| Chief Medical Officer | less than a year | データなし | データなし |
3.0yrs
平均在職期間
53yo
平均年齢
経験豊富な経営陣: DAWNの経営陣は 経験豊富 であると考えられます ( 2.8年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Director | 4yrs | US$6.91m | 1.71% $ 24.2m | |
| Independent Director | 4yrs | US$350.75k | 0.072% $ 1.0m | |
| Board Observer | no data | データなし | データなし | |
| Chairman of the Board & Lead Independent Director | 2yrs | US$383.38k | 0% $ 0 | |
| Board Observer | no data | データなし | データなし | |
| Independent Director | less than a year | データなし | 0% $ 0 | |
| Independent Director | 3.1yrs | US$342.88k | 0% $ 0 | |
| Independent Director | 4.8yrs | US$342.88k | 0% $ 0 | |
| Independent Director | 3.5yrs | US$351.75k | 0.041% $ 573.3k | |
| Independent Director | 3.6yrs | US$352.50k | 0.057% $ 811.5k | |
| Independent Director | less than a year | データなし | 0% $ 0 |
3.5yrs
平均在職期間
55yo
平均年齢
経験豊富なボード: DAWNの 取締役会 は 経験豊富 であると考えられます ( 3.3年の平均在任期間)。